Your session is about to expire
← Back to Search
TORL-3-600 for Advanced Cancer
Study Summary
This trial will examine the safety and effectiveness of a new cancer drug in patients with advanced cancer.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have any serious, uncontrolled illnesses or infections.I still experience side effects from past treatments, except for hair loss or acceptable lab results.I have not taken any cancer treatments recently before starting TORL-3-600.I am not pregnant or breastfeeding.I have had cancer before, but it was either a certain skin cancer or a low-risk type.My organs are working well.I have a history of serious heart problems.I am fully active or can carry out light work.I have a history of myelodysplastic syndrome or acute myeloid leukemia.My cancer is in an advanced stage and not just in one place.My brain cancer is getting worse or causing symptoms.
- Group 1: Monotherapy Dose Dose Finding - Part 1
- Group 2: Expansion as Monotherapy - Part 2
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What aims are the researchers attempting to attain through this clinical experiment?
"The primary goal of this clinical trial, which will take up to two years, is determine the Maximum Tolerated Dose (MTD). Secondary objectives include assessing Duration of Response (DOR), Progression Free Survival (PFS) and Time to Response (TTR)."
Is there still an opportunity for potential participants to join this experiment?
"According to clinicaltrials.gov, the last update for this particular trial was posted on July 9th 2023 and it is no longer recruiting patients. Nonetheless, there are still over 1600 medical trials currently seeking candidates at present time."
How reliable is the Monotherapy Dose Finding - Part 1 regimen for patient safety?
"Taking into account the limited safety and efficacy data, our team at Power has rated Monotherapy Dose Finding - Part 1 with a score of 1 on their scale."
Share this study with friends
Copy Link
Messenger